ArticleJournal of assisted reproduction and genetics2026
Morphokinetic parameter S2 predicts early embryo developmental potential and associated metabolic pathways.
Article in Journal of assisted reproduction and genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Ploidy and Implantation Potential: Non-Invasive Small Non-Coding RNA-Based Health Assessment of Day 5 and 6 Blastocysts.International journal of molecular sciences · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
purposeThe aim of this study was to determine the predictive value of the morphokinetic parameter S2 (the duration between cleavage from the 3-cell to 4-cell stage in the absence of direct cleavage) for early embryo developmental potential, establish its optimal cutoff value, and explore associated metabolic pathways.
methodsThis prospective study analyzed 662 embryos from 65 patients (September 2023-October 2024) which were cultured in time-lapse incubators. S2's predictive value for blastocyst formation/quality was assessed, with a cutoff value calculated through receiver operating characteristic (ROC) analysis. Subsequently, metabolomic profiling of spent culture media (SCM) from 20 patients was stratified by S2 cutoff using liquid chromatography-tandem mass spectrometry (LC-MS).
resultsAmong 662 embryos cultured in time-lapse incubators, 474 were analyzed to evaluate the association between S2 and developmental potential. Significant differences in S2 values were observed between the blastocyst formation vs. non-formation groups and high- vs. low-quality blastocyst groups (both median 0.5 vs. 0.8, P < 0.05). Logistic regression analysis showed that S2 predicted available blastocyst formation with an area under the curve (AUC) of 0.622 (95%CI = 0.559-0.685, P < 0.001) and blastocyst quality with an AUC of 0.645 (95% CI = 0.569-0.722), with an optimal cutoff of 0.7 h. Based on this cutoff, the day 3 (D3) SCM from 20 patients was divided into two groups (S2 < 0.7 and S2 ≥ 0.7) for metabolomic analysis. The results revealed 98 differentially expressed metabolites (59 upregulated and 39 downregulated), enriched in protein digestion/ absorption, aminoacyl-tRNA biosynthesis, fatty acid metabolism, central carbon metabolism in cancer, and glutamatergic synapse.
conclusionsThe S2 parameter (optimal cutoff = 0.70 h) shows moderate predictive capacity for embryo developmental potential (AUC = 0.64), with its regulation by specific metabolic pathways, supporting its inclusion in future multifactorial embryo evaluation models.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.